Navigation Links
FDNA Partners with London Medical Databases (LMD) to Provide Long-Awaited Online Access to Leading Dysmorphology Database
Date:8/26/2014

NEW YORK and LONDON, August 26, 2014 /PRNewswire/ --


 

FDNA Inc. (http://www.fdna.com) and London Medical Databases Ltd. (http://www.lmdatabases.com) announced today that they have partnered to offer, for the first time, online access to the award winning database exclusively through FDNA's solutions.

FDNA, developer of the Facial Dysmorphology Novel Analysis technology, will fully integrate LMD's award-winning collection into Face2Gene[TM], the only available dysmorphology genetic search and reference solution, using facial analysis technology. Combining the power of Face2Gene's advanced facial dysmorphology analysis and phenotype search algorithms and of LMD's comprehensive collection of images and medical reference into one, simple to use and accessible solution provides a robust solution for the genetics professionals' community.

"We are delighted to have partnered with FDNA. FDNA's unique technology, innovative solutions and strong commitment to the community of genetics professionals made them a perfect partner to carry our life's work of curation into the new era of dysmorphology," said Dr. Michael Baraitser, Co-Author of LMD. "Making LMD available online is a long awaited need. FDNA's innovative technology adds unparalleled value to our existing and new customers. This unique combination allows users to access the most updated LMD version anytime, anywhere and easily search for the most relevant references," added Dr. Baraitser.

LMD has become, over the past 20 years, the gold-standard dysmorphology reference for genetics professionals. The databases include a superb collection of over 20,000 images, which show dysmorphic features and other relevant medical images associated with a multitude of genetic disorders.

"Integrating LMD into Face2Gene combines the world's first and only available computer-aided dysmorphology analysis solution with the most reputable dysmorphology database collection. The partnership places unparalleled power and convenience in the hands of thousands of medical professionals," said Dekel Gelbman, CEO of FDNA Inc. "We are honored to partner with LMD. This partnership further underscores our commitment to the genetics community. We plan to continue enhancing Face2Gene in many ways, making it better and more useful," added Mr. Gelbman.

Under this partnership, Dr. Baraitser will join FDNA's scientific advisory board headed by Dr. Michael R. Hayden and comprised of some of key opinion leaders in genetics, Including Dr. David A. Chitayat, Prof. Jill Clayton-Smith, Dr. Cynthia J.R. Curry, Prof. Dian Donnai, Dr. Sofia Douzgou, Dr. Karen W. Gripp, Dr. Judith G. Hall, Prof. Arnold Munnich, Prof. Motti Shohat, and Prof. Lina Vanagaite-Basel.

About LMD:

Co-founded by Prof. Robin Winters and Dr. Michael Baraitser and edited by both until the premature death of Prof. Winter in 2003, LMD produces award-winning databases in the medical genetics field. With a worldwide user base built up over 20 years and drawing on the extensive clinical experience of their authors, the databases have become invaluable reference and diagnostic tools for the clinician. Currently the LMD series comprises: Winter-Baraitser Dysmorphology Database (WBDD), Baraitser-Winter Neurogenetics Database (BWDB) and London Ophthalmic Genetics Database (GENEEYE).  

About FDNA:

Face2Gene is a genetic search and reference solution powered by FDNA® (Facial Dysmorphology Novel Analysis) technology. Face2Gene facilitates detection of facial dysmorphic features and recognizable patterns of human malformations to present comprehensive and up-to-date genetic references. Face2Gene aids and empowers in accelerating and increasing confidence in the research and investigation of genetic syndromes. The solution leverages advanced algorithms and the cumulative experience of hundreds of genetics professionals and tens of thousands of analyzed cases. Face2Gene technology improves over time, referencing comprehensive phenotype databases in real-time.

Contact: FDNA Inc.
Yaron Front, V.P. Marketing
+1-(347)-305-0076
yaron.front@fdna.com


'/>"/>
SOURCE FDNA Inc.
Copyright©2014 PR Newswire.
All rights reserved

Related medicine technology :

1. Qmed, the Leading Global MedTech Industry Resource, Partners with Clarimed, to Provide the Medical Manufacturing and Healthcare Industry with FDA Reports on Adverse Events
2. Fuse Science Partners With GNC To Open National Distribution Of EnerJel™
3. Medical Guardian Announces Social Media Partnership with Senior Citizen Charity
4. The ALS Therapy Development Institute Partners with Neurotune to Investigate Potential Treatments for Motor Neuron Disease
5. ClearCanvas Partners With DPR to Offer CaseReader™, an Integrated Technology Structured Reporting Solution for Medical Imaging Professionals
6. VitaTech Adds New Capacity for Production and Customer Interface, Attributes Growth to Strategic Customer Partnerships
7. Bayer Partnership Delivers Industry-First Dose Management Offering
8. HUYA Bioscience International Engages In Partnership With Zhuhai Sanzao Science and Technology Industrial Park
9. Profil Institute Partners with Florida Hospital to Establish East Coast Center for Clinical Metabolic Research
10. Lilly Expands Strategic Partnership with Chinese Manufacturer Novast to Serve Chinese Patients with High-Quality Branded Generic Medicines
11. UBM Canon, the Global MedTech Authority, Partners with the World Medical Device Organization, WMDO, to Provide Medical Device Companies with Industry-Related Online Training Solutions
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/12/2016)... , Kalifornien, 12. Februar 2016  Sequent ... der Aufnahme von Patienten für eine Studie zur ... Aneurysmen („WEB") speziell für die Behandlung von rupturierten ... , MD, Leiter der Neuroradiologie an der Universitätsklinik ... und Hauptprüfarzt der CLARYS-Studie hat den ersten Patienten ...
(Date:2/12/2016)... , Feb. 12, 2016  Eli Lilly and Company ... Court decided the Alimta® (pemetrexed disodium) vitamin regimen patent would ... the UK, France , Italy ... to dilute the product only with dextrose solution.  ... 2015, the UK Court of Appeal held that Lilly,s patent ...
(Date:2/12/2016)... BUDAPEST , Ungarn, February 12, 2016 ... ein Medizintechnikunternehmen, das sich auf den ungedeckten ... gab heute positive Ergebnisse seines klinischen Forschungsprogramms ... und Asthma-Patienten beschäftigt, ergab Verbesserungen ihrer respiratorischen ... Indiso ltd , ein Medizintechnikunternehmen, das ...
Breaking Medicine Technology:
(Date:2/13/2016)... ... ... DDi , a Makro company, makes it to ... in eClinical Solutions. DDi has built its solution competency with a unique blend ... DDi provides smarter technology for Clinical Development, Regulatory and Enterprise domains by providing ...
(Date:2/12/2016)... , ... February 12, 2016 , ... ... devoted exclusively to funding innovative lymphoma research and serving the lymphoma community through ... over 250 members of South Florida’s philanthropic community at its 10th anniversary Fashion ...
(Date:2/12/2016)... ... 2016 , ... Coco Libre, the maker of coconut water beverages with a ... Lounge Event. Coco Libre will offer musicians and celebrities the company’s signature Organic Coconut ... invitation-only gifting suite, held this year at the W Hollywood Hotel, has become a ...
(Date:2/12/2016)... ... February 12, 2016 , ... Fisher House Foundation Chairman ... John J. Lee, Nevada Military Support Alliance president Scott Bensing, and Peggy Kearns Director, ... VA Southern Nevada Healthcare System. This will be the first Fisher House in ...
(Date:2/12/2016)... ... February 12, 2016 , ... Young ... area, celebrates the beginning of the latest charity campaign in their community enrichment ... art. Donations to this worthy cause are currently being accepted at: http://artexpressioninc.org/ ...
Breaking Medicine News(10 mins):